Although the lipopolysaccharide binding protein (LBP) levels and TLR-2 expression were found to be similar, TLR-4/MD-2 expression on CD14-positive cells was higher in the NASH patients than the control subjects [38]. The gene discussed is TLR2; the disease is metabolic dysfunction-associated steatohepatitis.